Cost-effectiveness of digital mammography breast cancer screening - Wikidata - awgldk - TriplyDB

Cost-effectiveness of digital mammography breast cancer screening

Cost-effectiveness of digital mammography breast cancer screening

http://www.wikidata.org/entity/Q37143624

about

Consequences of false-positive screening mammograms Bandit solutions provide unified ethical models for randomized clinical trials and comparative effectiveness research Economic evaluation research in the context of Child Welfare policy: a structured literature review and recommendations Comparative evaluation of digital mammography and film mammography: systematic review and meta-analysis Should patients with autosomal dominant polycystic kidney disease be screened for cerebral aneurysms?Cost-Effectiveness of Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer.Cost-effective screening for breast cancer worldwide: current state and future directions.Budget impact analysis of switching to digital mammography in a population-based breast cancer screening program: a discrete event simulation model.Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.Costs, evidence, and value in the Medicare program: the challenges of technology innovation in breast cancer prevention and control.Priorities for screening and treatment of latent tuberculosis infection in the United States A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years.Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines.Evolution of breast cancer screening in the Medicare population: clinical and economic implications.Imaging-based screening: understanding the controversies.Digital versus screen film mammography: a clinical comparison.Use of BI-RADS 3-probably benign category in the American College of Radiology Imaging Network Digital Mammographic Imaging Screening Trial.Computer disease simulation models: integrating evidence for health policy.Development and pilot testing of a decision aid for drivers with dementia.Transition from film to digital mammography: impact for breast cancer screening through the national breast and cervical cancer early detection program.Locally advanced breast cancer - strategies for developing nations.Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts.Does age or bilateral disease influence the value of hip arthroplasty?Effects of digital mammography uptake on downstream breast-related care among older women.The effects of indoor environmental exposures on pediatric asthma: a discrete event simulation model.Clarifying differences in natural history between models of screening: the case of colorectal cancer Multicohort models in cost-effectiveness analysis: why aggregating estimates over multiple cohorts can hide useful information Variation in tumor natural history contributes to racial disparities in breast cancer stage at diagnosis.Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography.Assessing health care use and cost consequences of a new screening modality: the case of digital mammography.Clinical outcomes of modelling mammography screening strategies.Total cost-effectiveness of mammography screening strategies Is Age-targeted full-field digital mammography screening cost-effective in emerging countries? A micro simulation model.Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.Molecular breast imaging: use of a dual-head dedicated gamma camera to detect small breast tumors.Cancer cases from ACRIN digital mammographic imaging screening trial: radiologist analysis with use of a logistic regression model.Cost and cost-effectiveness of digital mammography compared with film-screen mammography in Australia.Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy.An economic model of Parkinson's disease: implications for slowing progression in the United States.Breast cancer screening: review of benefits and harms, and recommendations for developing and low-income countries.

P2860

Q24563753-CC2DA113-1CBE-49F2-A63B-E345552F35A7 Q24657956-436DC6E1-EB34-43DC-8BA3-52DEB1B148D0 Q26824669-EA055D8D-8297-46EB-9E84-C5B57A9BE346 Q26851245-4AE4BDE0-9467-4B41-96E4-F70C0D657764 Q26862813-2BBF442A-65AC-471A-B4CB-28FEB52DD106 Q28267134-D156CB48-064F-40D4-A8F3-A8973F52EA56 Q30488485-E7E6A548-7A05-4829-BBD9-9CE4AE18331B Q33617993-3C90E9C1-F2E1-4EC0-807A-F9327BAEE4F9 Q33792616-797825B3-EF7E-4A35-8D28-DBA2FA69C27F Q33809046-177E725B-F60F-4A8A-9AD9-357761C94110 Q33895875-0DCF147D-DFFE-46E1-A045-0BC4E2E84AC0 Q34071767-46AB5686-324E-44CA-9337-F4DB60AF38A7 Q34079901-32A756D5-94A9-4738-A9EE-02FB1FC24AA4 Q34137696-8D70CCDE-12A7-4557-8EF2-89FACCCA114A Q34452684-3F895918-6D72-4E84-B346-366FD40F4B81 Q34991731-C9382006-1129-45AE-B785-41C94D292B95 Q35062110-FD8C37BC-7440-4C13-817E-65ECC38B9FBC Q35074556-6CE04E08-5665-4B66-A2A3-EA359D84A058 Q35123750-21A56503-A722-45FD-AFF6-6173DC86D2C8 Q35516764-4BF375C3-0020-437B-A890-3885AAD08005 Q35541051-CFC78DFD-620C-49AC-8681-CA55E10C729E Q35683407-FAA6AE42-E1BC-4F29-8198-C98DA0B30291 Q35802851-1368E826-4596-4D77-B023-4C80A98F9E92 Q36388896-7109413C-3DD9-4CCB-B17A-27CCC014637D Q36480468-8A2F0D49-96AF-4950-95C6-FDCDCF935D4A Q36493426-07BC1390-9C27-4F34-9C77-3DB837C85B1B Q36711336-B038DCE7-FC9C-4E7E-8837-2712988A832A Q36724704-63B5D985-43BA-4285-BD7E-FFE7F9C1EA86 Q36806768-E108B533-3D6E-4739-B701-1D406AE8BFF9 Q36833365-26E75144-472F-4ADC-932A-3F2911CB9D4E Q36908143-2E8F9F68-DBC6-45EC-AB16-7949813F6BA2 Q36972762-8E678279-EE62-483F-A7D0-4070323619AB Q37076741-2DAEBAF8-4CAF-4C2B-B041-32E6B285ED77 Q37139381-2E91E7D1-A719-4066-A6FF-945CED4D34DB Q37329846-1C00F004-C84C-4470-BB49-7D50D2A7465E Q37366885-EC4D4627-3078-44E4-A8AA-D41E1663DF0F Q37610494-00C058ED-3140-473E-8305-3964639D28EC Q37660161-6EEEE219-4AE1-4FD7-8B0A-C1EC5CB7003E Q38081100-7610ED5D-33F7-458C-8522-BE414A5AFCF8 Q38082665-90BBE30A-16AA-4779-AFB8-8C5418FA65DD

P2860

Cost-effectiveness of digital mammography breast cancer screening

http://www.wikidata.org/entity/Q37143624

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cost-effectiveness of digital mammography breast cancer screening

@en

Cost-effectiveness of digital mammography breast cancer screening.

@nl

type

label

Cost-effectiveness of digital mammography breast cancer screening

@en

Cost-effectiveness of digital mammography breast cancer screening.

@nl

prefLabel

Cost-effectiveness of digital mammography breast cancer screening

@en

Cost-effectiveness of digital mammography breast cancer screening.

@nl

P1433

Q37143624-73BD22F3-F9BF-495A-8145-C26654069DF0

P1476

Q37143624-200AEACF-D313-4AE1-8006-224A488290A6

P2093

Q37143624-23F7E2AC-1E28-4149-A5DB-65C47C108DE2

Q37143624-4B73F323-FC9D-4123-A609-7C7F294B2A06

Q37143624-4C8AAC1C-09F0-4FC0-AF66-C7560D278B56

Q37143624-84D69534-D96E-48B8-B1D8-AA684155EB04

Q37143624-A3132C41-AE74-41A7-8BFC-E8D9D763BAE6

Q37143624-D04061F1-4AC9-43C3-8D63-22AEC35311E4

Q37143624-DDFF583F-6100-4207-9C2A-151B4C443017

Q37143624-F51C15CD-C6F9-43A8-839A-4DEE839963CB

P2860

Q37143624-009FC206-1711-4C2B-B0E4-2BB6771941DD

Q37143624-10EA6072-2493-4627-8C9A-EC0A652F249C

Q37143624-1CAE726C-C5D4-4801-9EBA-98699DE8B5B8

Q37143624-243D2B5D-0F53-47AC-9302-02CB6F707BD3

Q37143624-28DAF71D-5426-4C0F-AACB-E8C53623F14C

Q37143624-418CACB0-6DDA-44BB-87E7-30F2E1DD9E85

Q37143624-4663C9ED-90BD-46E4-9251-A1F07F710E61

Q37143624-6410FB42-6E19-414A-B9E3-A56E8B248898

Q37143624-6492CD0F-4CDD-4CF6-A2A4-FC9B572058DD

Q37143624-67A2939B-C33E-473C-A0BC-180D69E17698

P304

Q37143624-63C8041B-8CF3-403E-B94F-AD80AA9A2D9A

P31

Q37143624-B030E34E-5B61-45D5-861B-893E2F994D56

P356

Q37143624-75091BC1-4788-482D-B604-C141184130A8

P407

Q37143624-704231F0-35D5-4609-821D-E36B9DDC9224

P433

Q37143624-F7A2E3AA-3872-44E1-BA00-C2CEE40085D6

P478

Q37143624-4C885E59-0684-4C27-9390-1FF29ADF24FE

P577

Q37143624-9EEF312F-84AF-4FDF-8540-20AE2417C352

P698

Q37143624-FA46441F-BE84-487D-9595-031307A34512

P932

Q37143624-3A1653A4-BE05-49AC-AAE4-6ED2D4617576

P356

0003-4819-148-1-200801010-00002

P1433

Annals of Internal Medicine

P1476

Cost-effectiveness of digital mammography breast cancer screening

@en

P2093

Anna N A Tosteson

http://www.w3.org/2001/XMLSchema#string

Benjamin A Herman

http://www.w3.org/2001/XMLSchema#string

DMIST Investigators

http://www.w3.org/2001/XMLSchema#string

Dennis G Fryback

http://www.w3.org/2001/XMLSchema#string

Etta D Pisano

http://www.w3.org/2001/XMLSchema#string

Lucy G Hannah

http://www.w3.org/2001/XMLSchema#string

Natasha K Stout

http://www.w3.org/2001/XMLSchema#string

Suddhasatta Acharyya

http://www.w3.org/2001/XMLSchema#string

P2860

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.

Effect of screening and adjuvant therapy on mortality from breast cancer.

Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.

The decrease in breast-cancer incidence in 2003 in the United States.

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.

Breast cancer risk factors in relation to breast density (United States).

The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force.

Two-modality mammography may confer an advantage over either full-field digital mammography or screen-film mammography.

P304

1-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7326/0003-4819-148-1-200801010-00002

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

148

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18166758

http://www.w3.org/2001/XMLSchema#string

P932

2662630

http://www.w3.org/2001/XMLSchema#string